Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polyoxidonium in hospitalized adults with COVID-19
2020-001782-37Phase 2Completed
- Sponsor
- Petrovax Pharm
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Polyoxidonium 12 mg with Placebo (2 arms). Primary endpoint: Clinical status at Day 15 on 7-point ordinal scale. Started Jun 2020; status: completed.
02
Drugs
azoximer bromide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001782-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001782-37.